Weed ETF waives fee ahead of much-awaited drug relabeling
The sector-focused fund will sport a zero percent expense ratio for a limited time as regulators move to reclassify the substance.
Roundhill Investments is completely waiving the fee for its $5.6 million cannabis fund as US regulators move to reclassify marijuana as a less dangerous substance.
Starting Monday, the actively managed Roundhill Cannabis ETF (ticker WEED) is dropping its expense ratio to zero from 40 basis poin
Learn more about reprints and licensing for this article.
